心脏遗传学心理学家:一种观点,主张在患者护理中发挥结构化的作用
Saartje Van Pottelberghe1,2, Nina Kupper3, Frederik Hes4,5
1Genetics, Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium. saartje.vanpottelberghe@uzbrussel.be.
Journal of clinical psychology in medical settings
|February 25, 2026
概括
心理支持不一致地被整合到遗传性心脏病 (ICC) 护理中. 将心理学家纳入心脏遗传学团队可以改善患者的沟通,决策和长期福祉.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 心理学 心理学 心理学
背景情况:
- 遗传性心脏病 (ICC) 需要终身治疗,并为患者带来重大心理挑战.
- 心理护理与其他遗传学领域 (如瘤遗传学,生殖遗传学和神经遗传学) 相比,不一致地被整合到心脏遗传学中.
- 心脏遗传学传统上将医疗管理优先于心理社会需求,使患者容易受到痛苦和不确定性的影响.
研究的目的:
- 倡导心理学家在心脏遗传护理团队中的结构化整合.
- 突出不同遗传学学科在心理支持方面的差异.
- 强调需要加强以患者为中心的沟通和心脏遗传学的决策.
主要方法:
- 这种观点借鉴了国际经验,并观察到不同中心和国家的心理护理差异.
- 它分析了心脏遗传学中心理支持的当前状态.
- 它比较了心理学家在心脏遗传学与其他专业遗传学领域的整合.
主要成果:
- 患有ICC的患者会经历严重的痛苦,悲伤和不确定性,特别是在发现遗传风险时.
- 病原体变种的携带者与内,传播恐惧和家庭沟通作斗争,影响医疗遵守.
- 在不同国家和临床环境中提供心理支持方面存在差异.
结论:
- 迫切需要将心理学家纳入心脏遗传护理团队.
- 结构化的心理支持对于改善以患者为中心的沟通,知情决策和长期心理社会福祉至关重要.
- 解决心理需求对于对遗传性心脏病的有效终身管理至关重要.
更多相关视频
相关概念视频
01:28Human Genetics
1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
01:29Cardiomyopathy V: Interprofessional Care
520
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
555
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
01:29Pharmacogenomics: Identification of New Drug Targets
49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
01:27Coronary Artery Disease V: Interprofessional Care
325
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
325
01:29Pharmacogenetics and Pharmacogenomics: Overview
70
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
70